Human CFLAR/c-FLIP/c-FLIPL ORF/cDNA clone-Adenovirus particle (BC001602)

Cat. No.: vGMAP000345

Pre-made Human CFLAR/c-FLIP/c-FLIPL Adenovirus for CFLAR overexpression in-vitro and in-vivo. The CFLAR adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified CFLAR-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.

At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.

Target products collection

Go to CFLAR/FLIP/CFLAR/c-FLIP products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name Adenovirus Grade Adenovirus quantity
vGMAP000345 Human CFLAR Adenovirus particle Research Grade-In vitro 1E+10PFU (1E+10pfu/ml×1ml)
5E+10PFU (1E+10pfu/ml×5ml)
1E+11PFU (1E+10pfu/ml×10ml)
Research Grade-In vivo 1E+11PFU (1E+11pfu/ml×1ml)
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAP000345
Gene Name CFLAR
Accession Number BC001602
Gene ID 8837
Species Human
Product Type Adenovirus particle (overexpression)
Insert Length 1443 bp
Gene Alias c-FLIP,c-FLIPL,c-FLIPR,c-FLIPS,CASH,Casper,CLARP,FLAME,FLAME-1,FLIP,I-FLICE,MRIT,USURPIN
Fluorescent Reporter GFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Amplicin
ORF Nucleotide Sequence ATGTCTGCTGAAGTCATCCATCAGGTTGAAGAAGCACTTGATACAGATGAGAAGGAGATGCTGCTCTTTTTGTGCCGGGATGTTGCTATAGATGTGGTTCCACCTAATGTCAGGGACCTTCTGGATATTTTACGGGAAAGAGGTAAGCTGTCTGTCGGGGACTTGGCTGAACTGCTCTACAGAGTGAGGCGATTTGACCTGCTCAAACGTATCTTGAAGATGGACAGAAAAGCTGTGGAGACCCACCTGCTCAGGAACCCTCACCTTGTTTCGGACTATAGAGTGCTGATGGCAGAGATTGGTGAGGATTTGGATAAATCTGATGTGTCCTCATTAATTTTCCTCATGAAGGATTACATGGGCCGAGGCAAGATAAGCAAGGAGAAGAGTTTCTTGGACCTTGTGGTTGAGTTGGAGAAACTAAATCTGGTTGCCCCAGATCAACTGGATTTATTAGAAAAATGCCTAAAGAACATCCACAGAATAGACCTGAAGACAAAAATCCAGAAGTACAAGCAGTCTGTTCAAGGAGCAGGGACAAGTTACAGGAATGTTCTCCAAGCAGCAATCCAAAAGAGTCTCAAGGATCCTTCAAATAACTTCAGGCTCCATAATGGGAGAAGTAAAGAACAAAGACTTAAGGAACAGCTTGGCGCTCAACAAGAACCAGTGAAGAAATCCATTCAGGAATCAGAAGCTTTTTTGCCTCAGAGCATACCTGAAGAGAGATACAAGATGAAGAGCAAGCCCCTAGGAATCTGCCTGATAATCGATTGCATTGGCAATGAGACAGAGCTTCTTCGAGACACCTTCACTTCCCTGGGCTATGAAGTCCAGAAATTCTTGCATCTCAGTATGCATGGTATATCCCAGATTCTTGGCCAATTTGCCTGTATGCCCGAGCACCGAGACTACGACAGCTTTGTGTGTGTCCTGGTGAGCCGAGGAGGCTCCCAGAGTGTGTATGGTGTGGATCAGACTCACTCAGGGCTCCCCCTGCATCACATCAGGAGGATGTTCATGGGAGATTCATGCCCTTATCTAGCAGGGAAGCCAAAGATGTTTTTTATTCAGAACTATGTGGTGTCAGAGGGCCAGCTGGAGGACAGCAGCCTCTTGGAGGTGGATGGGCCAGCGATGAAGAATGTGGAATTCAAGGCTCAGAAGCGAGGGCTGTGCACAGTTCACCGAGAAGCTGACTTCTTCTGGAGCCTGTGTACTGCGGACATGTCCCTGCTGGAGCAGTCTCACAGCTCACCATCCCTGTACCTGCAGTGCCTCTCCCAGAAACTGAGACAAGAAAGAAAACGCCCACTCCTGGATCTTCACATTGAACTCAATGGCTACATGTATGATTGGAACAGCAGAGTTTCTGCCAAGGAGAAATATTATGTCTGGCTGCAGCACACTCTGAGAAAGAAACTTATCCTCTCCTACACATAA
ORF Protein Sequence MSAEVIHQVEEALDTDEKEMLLFLCRDVAIDVVPPNVRDLLDILRERGKLSVGDLAELLYRVRRFDLLKRILKMDRKAVETHLLRNPHLVSDYRVLMAEIGEDLDKSDVSSLIFLMKDYMGRGKISKEKSFLDLVVELEKLNLVAPDQLDLLEKCLKNIHRIDLKTKIQKYKQSVQGAGTSYRNVLQAAIQKSLKDPSNNFRLHNGRSKEQRLKEQLGAQQEPVKKSIQESEAFLPQSIPEERYKMKSKPLGICLIIDCIGNETELLRDTFTSLGYEVQKFLHLSMHGISQILGQFACMPEHRDYDSFVCVLVSRGGSQSVYGVDQTHSGLPLHHIRRMFMGDSCPYLAGKPKMFFIQNYVVSEGQLEDSSLLEVDGPAMKNVEFKAQKRGLCTVHREADFFWSLCTADMSLLEQSHSSPSLYLQCLSQKLRQERKRPLLDLHIELNGYMYDWNSRVSAKEKYYVWLQHTLRKKLILSYT

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP0138-Ab Anti-CFLAR monoclonal antibody
    Target Antigen GM-Tg-g-IP0138-Ag CFLAR protein
    ORF Viral Vector pGMLP000484 Human CFLAR Lentivirus plasmid
    ORF Viral Vector pGMAP000345 Human CFLAR Adenovirus plasmid
    ORF Viral Vector vGMLP000484 Human CFLAR Lentivirus particle
    ORF Viral Vector vGMAP000345 Human CFLAR Adenovirus particle


    Target information

    Target ID GM-IP0138
    Target Name CFLAR/FLIP
    Gene Group Identifier
    （Target Gene ID in Homo species)         		8837
    Gene ID 100068181 (Equus caballus), 100142680 (Felis catus), 117279 (Rattus norvegicus), 12633 (Mus musculus)
    488471 (Canis lupus familiaris), 497199 (Bos taurus), 574234 (Macaca mulatta), 8837 (Homo sapiens)
    Gene Symbols & Synonyms CFLAR,Cflar,FLIP,Flip,Cash,MRIT,CLARP,FLAME,Casper,Gm9845,c-Flip,FLAME-1,I-FLICE,2310024N18Rik,A430105C05Rik,CASH,cFLIP,FLAME1,c-FLIP,c-FLIPL,c-FLIPR,c-FLIPS,CASP8AP1
    Target Alternative Names 2310024N18Rik,A430105C05Rik,CASH,CASP8 and FADD-like apoptosis regulator,CASP8AP1,CFLAR,CLARP,Cash,Caspase homolog (CASH),Caspase-eight-related protein (Casper),Caspase-like apoptosis regulatory protein (CLARP),Casper,Cellular FLICE-like inhibitory protein (c-FLIP),Cflar,FADD-like antiapoptotic molecule 1 (FLAME-1),FLAME,FLAME-1,FLAME1,FLIP,Flip,Gm9845,I-FLICE,Inhibitor of FLICE (I-FLICE),MACH-related inducer of toxicity (MRIT),MRIT,Usurpin,c-FLIP,c-FLIPL,c-FLIPR,c-FLIPS,c-Flip,cFLIP
    Uniprot Accession O15519,O35732
    Additional SwissProt Accessions: O35732,O15519
    Uniprot Entry Name
    Protein Sub-location Introcelluar Protein
    Category Therapeutics Target
    Disease cancer
    Disease from KEGG NF-kappa B signaling pathway, Apoptosis, TNF signaling pathway, Chagas disease, Hepatitis C
    Gene Ensembl ENSECAG00000021300, ENSMUSG00000026031, ENSCAFG00845029893, ENSBTAG00000010998, ENSMMUG00000012310, ENSG00000003402
    Target Classification Tumor-associated antigen (TAA)


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.